Specialty pharmaceuticals are the fastest-growing segment of the pharmacy business, but the sizable opportunity that they represent comes with a steep learning curve for new participants in the market.
So noted the participants in a panel discussion at ECRM's recent specialty pharmacy event in New Orleans.
The ECRM panelists included Avella's Leslie Yendro, Diplomat's Cheryl Allen, Two Lab's Will Pih, and Takeda's Chris Glessinge